CEL-SCI raises $4.98M in registered direct offering at $2.00/share; proceeds for Multikine development

CEL SCI CORP

Issued 2,490,000 shares at $2.00 per share to a single investor; gross proceeds ~$4.98M.
Underwriters purchased at $1.86/share; ThinkEquity acted as sole book-running manager.
Offering closed on November 20, 2023.
Net proceeds to fund continued development of Multikine, general corporate purposes, and working capital.

item 1.01 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

CEL SCI CORP entered into Underwriting Agreement with ThinkEquity LLC valued at $4,980,000 (effective 2023-11-15).

Action: entry
Agreement: underwriting
Counterparty: ThinkEquity LLC
Value: $4,980,000
Effective: 2023-11-15

Exact text from the filing

On November 15, 2023, CEL-SCI Corporation, a Colorado corporation (the “Company”), entered into an underwriting agreement (the “Underwriting Agreement”) with ThinkEquity LLC, as the representative (the “Representative”) of the several underwriters named therein, if any (collectively, the “Underwriters”), relating to the issuance and sale (the “Offering”) of 2,490,000 shares of the Company’s common stock, par value $0.01 per share, to a single investor at an offering price of $2.00 per share (the “Shares”).

View on SEC.gov

800 material agreements filed in the last 30 days. Browse all material agreements →

CEL SCI CORP filing history →

Source: SEC EDGAR

accession 0001654954-23-014628

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.